BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 18785850)

  • 1. Take control over your fluconazole prescriptions: the growing importance of Candida glabrata as an agent of candidemia in Brazil.
    Pasqualotto AC; Zimerman RA; Alves SH; Aquino VR; Branco D; Wiltgen D; do Amaral A; Cechinel R; Colares SM; da Rocha IG; Severo LC; Sukiennik TC
    Infect Control Hosp Epidemiol; 2008 Sep; 29(9):898-9. PubMed ID: 18785850
    [No Abstract]   [Full Text] [Related]  

  • 2. Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links.
    Sendid B; Cotteau A; François N; D'Haveloose A; Standaert A; Camus D; Poulain D
    BMC Infect Dis; 2006 May; 6():80. PubMed ID: 16670011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empirical treatment of candidemia in intensive care units: fluconazole or broad-spectrum antifungal agents?
    Guinea J; Peláez T; Rodríguez-Créixems M; Torres-Narbona M; Muñoz P; Alcalá L; Bouza E
    Med Mycol; 2009; 47(5):515-20. PubMed ID: 18972315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida glabrata fungaemia in intensive care units.
    Ruan SY; Lee LN; Jerng JS; Yu CJ; Hsueh PR
    Clin Microbiol Infect; 2008 Feb; 14(2):136-40. PubMed ID: 18042196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
    Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
    J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and treatment of hematogenous candidiasis: a Brazilian perspective.
    Colombo AL
    Braz J Infect Dis; 2000 Jun; 4(3):113-8. PubMed ID: 10934493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing incidence of Candida parapsilosis candidemia with caspofungin usage.
    Forrest GN; Weekes E; Johnson JK
    J Infect; 2008 Feb; 56(2):126-9. PubMed ID: 18082269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of breakthrough Candida bloodstream isolates correlates with daily and cumulative doses of fluconazole.
    Clancy CJ; Staley B; Nguyen MH
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3496-8. PubMed ID: 17005842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida glabrata fungemia: experience in a tertiary care center.
    Malani A; Hmoud J; Chiu L; Carver PL; Bielaczyc A; Kauffman CA
    Clin Infect Dis; 2005 Oct; 41(7):975-81. PubMed ID: 16142662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida glabrata fungemia cured by antibiotic-lock therapy: case report and short review.
    Angel-Moreno A; Boronat M; Bolaños M; Carrillo A; González S; Pérez Arellano JL
    J Infect; 2005 Oct; 51(3):e85-7. PubMed ID: 16230210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing trends in the epidemiology of Candida blood stream infections: a matter for concern?
    Sobel JD
    Crit Care Med; 2010 Mar; 38(3):990-2. PubMed ID: 20168159
    [No Abstract]   [Full Text] [Related]  

  • 13. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
    Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
    Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multicenter study of fungemia due to yeasts in Argentina].
    Rodero L; Davel G; Soria M; Vivot W; Córdoba S; Canteros CE; Saporiti A;
    Rev Argent Microbiol; 2005; 37(4):189-95. PubMed ID: 16502638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
    Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
    Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and outcome of multiple-species candidemia at a tertiary care center between 2004 and 2007.
    Nace HL; Horn D; Neofytos D
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):289-94. PubMed ID: 19376670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007.
    Poikonen E; Lyytikäinen O; Anttila VJ; Koivula I; Lumio J; Kotilainen P; Syrjälä H; Ruutu P
    BMC Infect Dis; 2010 Oct; 10():312. PubMed ID: 21029444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiology of fungemia in a university hospital; therapeutic incidence].
    Pavese P; Brion JP; Lebeau B; Grillot R; Ambroise-Thomas P
    Pathol Biol (Paris); 1999 May; 47(5):579-83. PubMed ID: 10418046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candidemia in neonatal intensive care unit.
    Gupta N; Mittal N; Sood P; Kumar S; Kaur R; Mathur MD
    Indian J Pathol Microbiol; 2001 Jan; 44(1):45-8. PubMed ID: 12561995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candidemia in patients with hematologic malignancies: analysis of 7 years' experience in a single center.
    Vigouroux S; Morin O; Moreau P; Harousseau JL; Milpied N
    Haematologica; 2006 May; 91(5):717-8. PubMed ID: 16670081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.